Table 1.
Structure | Metric | Maximum |
Middle range |
Minimum |
|||
---|---|---|---|---|---|---|---|
Score | Criteria | Score | Criteria | Score | Criteria | ||
CTV | % covered by TD | 20 | 100–99.5% | 19.9–0.1 | 99.6–99% | 0 | <98.9% |
PTV | % covered by TD | 20 | 100–95% | 19.9–0.1 | 94.9–90% | 0 | <89.9% |
% covered by 95%TD | 10 | 100–99% | 9.9–0.1 | 98.9–98 | 0 | <97.9% | |
% covered by 107%TD | 10 | <1% | 9.9–0.1 | 1.1–2% | 0 | >2% | |
% covered by 105%TD | 10 | 0% | 0 | >15% | |||
Mean dose | 5 | 81–83 Gy | 2.9–0.1 | 84.6 –85.6 Gy | 0 | >85.6 Gy | |
Homogeneity Index | 5 | 0.02 | 0 | >0.15 | |||
Conformation Number | 5 | 1 | 4.9–4 3.9–0 |
0.9–0.7 0.69–0.51 |
0 | <0.5 | |
Volume (cc) covered by TD outside PTV | 10 | 8–10 cc | 7.9–0 | 10.1–20 cc | 0 | >20 cc | |
Rectum | Volume (cc) covered by 102.5%TD | 0 | <2 cc | 0.1 to −5 | 2–3 cc | −5 | >3 cc |
% covered by 40 Gy | 10 | <35% | 8–10 7.9–0.1 |
35.1–40% 40.1–45% |
0 | >45% | |
% covered by 65 Gy | 10 | <17% | 9.9–0.1 | 17.1–21% | 0 | >21% | |
% covered by 75 Gy | 10 | <10% | 9.9–0.1 | 10.1–15% | 0 | >15% | |
Coverage of 50%TD axial slice evaluation | 0 | Pass | −10 | Fail | |||
Bladder | % covered by 60 Gy | 5 | <35% | 4.9–0.1 | 35.1–40% | 0 | >40% |
% covered by 40 Gy | 5 | <50% | 4.9–0.1 | 50.1–60% | 0 | >60% | |
Penile bulb | % covered by 50 Gy | 2 | <95% | 1.9–0.1 | 95.1–100% | 0 | >100% |
Rt femoral head | % covered by 45 Gy | 2 | <2% | 1.9–0.1 | 2–5% | 0 | >5% |
Lt femoral head | % covered by 45 Gy | 2 | <2% | 1.9–0.1 | 2–5% | 0 | >5% |
Patient | Volume (cc) covered by 110%TD | 0 | <2 cc | −0.1 to −5 | 2–5 cc | −5 | >5 cc |
Global max location | Within CTV/PTV/elsewhere/rectum | 5 | CTV | 3 0 |
PTV Elsewhere |
−5 | Rectum |
Abbreviations: CTV, clinical target volume; PTV, planning target volume; TD, total dose (Gy).
Definitions: Homogeneity Index = [Dose covering 1% of PTV − Dose covering 99% of PTV] (Gy)/Prescribed dose (Gy). The prescribed dose was 81 Gy.
Conformation number = [PTV (cc) covered by specified dose (95% in Gy)]2/[Total volume covered by 95% dose (Gy) × Total volume of PTV (cc)].